Back to Search Start Over

Discovery of a chemical probe for PRDM9.

Authors :
Allali-Hassani A
Szewczyk MM
Ivanochko D
Organ SL
Bok J
Ho JSY
Gay FPH
Li F
Blazer L
Eram MS
Halabelian L
Dilworth D
Luciani GM
Lima-Fernandes E
Wu Q
Loppnau P
Palmer N
Talib SZA
Brown PJ
Schapira M
Kaldis P
O'Hagan RC
Guccione E
Barsyte-Lovejoy D
Arrowsmith CH
Sanders JM
Kattar SD
Bennett DJ
Nicholson B
Vedadi M
Source :
Nature communications [Nat Commun] 2019 Dec 17; Vol. 10 (1), pp. 5759. Date of Electronic Publication: 2019 Dec 17.
Publication Year :
2019

Abstract

PRDM9 is a PR domain containing protein which trimethylates histone 3 on lysine 4 and 36. Its normal expression is restricted to germ cells and attenuation of its activity results in altered meiotic gene transcription, impairment of double-stranded breaks and pairing between homologous chromosomes. There is growing evidence for a role of aberrant expression of PRDM9 in oncogenesis and genome instability. Here we report the discovery of MRK-740, a potent (IC <subscript>50</subscript> : 80 ±â€‰16 nM), selective and cell-active PRDM9 inhibitor (Chemical Probe). MRK-740 binds in the substrate-binding pocket, with unusually extensive interactions with the cofactor S-adenosylmethionine (SAM), conferring SAM-dependent substrate-competitive inhibition. In cells, MRK-740 specifically and directly inhibits H3K4 methylation at endogenous PRDM9 target loci, whereas the closely related inactive control compound, MRK-740-NC, does not. The discovery of MRK-740 as a chemical probe for the PRDM subfamily of methyltransferases highlights the potential for exploiting SAM in targeting SAM-dependent methyltransferases.

Details

Language :
English
ISSN :
2041-1723
Volume :
10
Issue :
1
Database :
MEDLINE
Journal :
Nature communications
Publication Type :
Academic Journal
Accession number :
31848333
Full Text :
https://doi.org/10.1038/s41467-019-13652-x